Skip to main content
HR 6620 116th Congress House

To authorize grants to address substance use during COVID-19.

Introduced: April 24, 2020 See on congress.gov
Health Cardiovascular and respiratory healthDigestive and metabolic diseasesDrug, alcohol, tobacco useEmergency medical services and trauma care
More subjectsShow fewer subjects
HIV/AIDSHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesInfectious and parasitic diseasesMental health
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 24, 2020
Referred to the House Committee on Energy and Commerce.
Apr 24, 2020
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 24, 2020

Referred to the House Committee on Energy and Commerce.

 Plain-English summary Congressional Research Service

This bill requires the Substance Abuse and Mental Health Services Administration (SAMHSA) to award grants to eligible jurisdictions and community-based organizations to address the harms of substance misuse, including by encouraging actions to reduce health impacts of substance use during national disasters and emergencies. SAMHSA shall prioritize grants by accounting for such factors as drug overdose death rates.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6620: To authorize grants to address substance use during COVID-19.. 116th Congress. Open America. https://openamerica.io/bill/116-HR-6620/
MLA
"H.R. 6620: To authorize grants to address substance use during COVID-19.." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-6620/.
Bluebook (legal)
H.R. 6620, 116th Cong. (2026), https://openamerica.io/bill/116-HR-6620/.
Markdown link
[H.R. 6620: To authorize grants to address substance use during COVID-19.](https://openamerica.io/bill/116-HR-6620/)
Report a problem